!!Simon Cauchemez - Curriculum Vitae
\\
__EDUCATION__
\\
*2002 - 2005	PhD in Biostatistics, Université Pierre et Marie Curie, Paris, France\\
*2001 - 2002	Master in Biomathematics, Université Pierre et Marie Curie, Paris, France \\
*1998 - 2001	ENSAE in statistics / economics, Malakoff, France. ENSAE is the National School for Statistics and Economic Administration
\\
__OTHER__
\\
*2024 - now Member of the Scientific Advisory Board (SAB) of CARE, Center for African Resilience for Epidemics, Senegal\\
*2023 - now Member of the SAB of the MRC Center for Global Infectious Diseases Analysis, Imperial College London, UK\\
*2022 - now Member of COVARS, French committee for monitoring and anticipating health Risks\\
*2022 - now Member of the SAB of OptimAgent modelling project, Germany\\
*2022 - now Member of the SAB of the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Modelling and Health Economics, UK\\
*2022 - now Member of the SAB of Domaine d’Intérêt Majeur (DIM) One Health, Région Ile de France\\
*2021 - now Co-President of the Coordinated Action in charge of coordinating French research on infectious disease modelling at ANRS-MIE \\
*2021 - now Member of the Board of Reviewing Editors of the journal Science\\
*2021 - now Co-director of the 1-week course Modelling of Infectious Diseases, Institut Pasteur\\
*2020 - 2022 Member of the COVID19 Scientific Council of the Ministry of Health, France \\
*2020 - 2024 Member of the Population and Public Health Expert Review Group, Wellcome Trust\\
*2019 - 2021 Member of the steering committee of US NIGMS Models of Infectious Disease Agent Study (MIDAS) \\
*2018 - 2021 Member of COMESP, the committee in charge of evaluating scientists at Institut Pasteur. President of subcommittee about modelling, biostatistics and bioinformatics\\
*2017 - now Member of the Scientific Advisory Board of Institut Pasteur Madagascar\\
*2017 - 2020 Member of the Scientific Advisory Board of Institut Pasteur Cambodia
\\
__CURRENT GRANTS__
\\
*2025	        Labex IBEID, “Analysis and modelling of infectious diseases epidemics to support evidence based policy making in France”, PI, 60k €.\\
*2024 - 2031	Wellcome Trust, Risk Assessment Community Spread Multiple Endemic Infectious Pathogens (RACSMEI), co-Investigator, 400k €.\\
*2024 - 2026	HAS, Modelling of vaccination strategies for HAS recommendations, PI, up to 200k €.\\
*2024 - 2025	EU LEAPS, Integrating Multi-Disciplinary Expertise in a Learning and Adaptive European Pandemic Preparedness System, Co-investigator, 110k €.\\
*2023 - 2027	EU DURABLE, Delivering a Unified Research Alliance of Biomedical and public health Laboratories against Epidemics, Workpackage leader, 515k €.\\
*2023 - 2025	AXARF, Influenza virus antibody landscapes to decipher the drivers of influenza epidemics, PI, 291k €.\\
*2022 - 2024	ANRS-MIE, MPX-SPREAD, Characterizing the spreading dynamics of 2022 monkeypox outbreak in France to aid public health policies, Co-Investigator, 34k €.\\
*2021 - 2025	NIH, PICREID Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa, Co-investigator, 220k $.\\
*2020 - 2025	EU H2020 VEO, Versatile Emerging infectious disease Observatory, Co-investigator, 198k €.\\ \\[{ALLOW view All}][{ALLOW edit scauchemez}][{ALLOW upload scauchemez}][{ALLOW comment All}]